Search results
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 5 days agoAbbVie ABBV announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 5 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 ...
AbbVie’s SKYRIZI gains US FDA approval for ulcerative colitis
Pharmaceutical Technology via Yahoo Finance· 5 days agoAbbVie has announced receipt of US Food and Drug Administration (FDA) approval for SKYRIZI...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 5 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 3 days agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
AbbVie's Skyrizi Gets FDA Approval to Treat Certain Instances of Ulcerative Colitis
Market Watch· 5 days agoPublished: June 18, 2024 at 6:36 p.m. ETShareResizeBy Sabela OjeaAbout Dow Jones NewswiresDow Jones Newswires is a market-moving financial and business news source, used by wealth managers, ...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 4 days agoWith the nod from the FDA, Skyrizi joins Rinvoq as immunology drugs in the AbbVie pipeline approved for both IBD conditions, UC and Crohn's. With the arrival of biosimilar ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 4 days agoOn June 20, 2024, AbbVie Inc. (NYSE:ABBV) announced that it has received FDA approval for expanding the use of its interleukin-23 (IL-23) inhibitor, Skyrizi, to treat adults ...
As AbbVie Drug Gets FDA Nod, Traders Can Look Up to These Targets
TheStreet.com· 4 days agoAbbVie (ABBV) on Wednesday won Food and Drug Administration approval for a new use for its drug ...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 4 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...